| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 04/28/2004 | EP1412384A2 Stable formulation of modified glp-1 |
| 04/28/2004 | EP1412382A2 Interferon gamma polypeptide variants |
| 04/28/2004 | EP1412377A1 Production of high molecular mass lectins |
| 04/28/2004 | EP1412366A1 Compounds for use as surfactants |
| 04/28/2004 | EP1412360A1 COMBINATION THERAPY OF AN SODm AND A CORTICOSTEROID FOR PREVENTION AND/OR TREATMENT OF INFLAMMATORY DISEASE |
| 04/28/2004 | EP1412324A2 Amino acid conjugates providing for sustained systemic concentrations of gaba analogues |
| 04/28/2004 | EP1412175A1 Insulating and functionalizing fine metal-containing particles with comformal ultra-thin films |
| 04/28/2004 | EP1412068A2 Emulsifier mixture |
| 04/28/2004 | EP1412028A1 Tetrahydroindolone and purine derivatives linked to arylpiperazines |
| 04/28/2004 | EP1411988A1 Mixed complexes for masking the taste of bitter active substances |
| 04/28/2004 | EP1411987A2 Targeted polymeric delivery systems |
| 04/28/2004 | EP1411986A1 Composition for epigallocatechin gallate |
| 04/28/2004 | EP1411979A1 Vaccine comprising gp120 and nef and/or tat for the immunisation against hiv |
| 04/28/2004 | EP1411955A1 Sucralose formulations to mask unpleasant tastes |
| 04/28/2004 | EP1411926A1 Integrin inhibitors for the treatment of eye diseases |
| 04/28/2004 | EP1411923A1 Pharmaceutical compositions of amlodipine and atorvastatin |
| 04/28/2004 | EP1411921A1 Pharmaceutical compositions containing terbinafin and use thereof |
| 04/28/2004 | EP1411915A2 Nitrate ester-cyclodextrin complexes for treating diseases, particularly coronary diseases |
| 04/28/2004 | EP1411913A1 Antimicrobial nanoemulsion compositions and methods |
| 04/28/2004 | EP1411910A1 (+)-cycloolivil as antioxidant obtained from stereospermum personatum |
| 04/28/2004 | EP1411908A1 Treatment of nail infections with no |
| 04/28/2004 | EP1411904A1 Sustained release pharmaceutical composition |
| 04/28/2004 | EP1411903A2 Biodegradable polyhydric alcohol esters |
| 04/28/2004 | EP1411901A1 Gastric retention controlled drug delivery system |
| 04/28/2004 | EP1411899A2 Taste masking composition |
| 04/28/2004 | EP1411898A1 Pharmaceutical composition comprising lipids with a polar and a nonpolar moiety |
| 04/28/2004 | EP1411897A2 Compositions and methods for intracellular delivery |
| 04/28/2004 | EP1411896A2 Surfactant compounds and uses thereof |
| 04/28/2004 | EP1411895A2 Oral pharmaceutical composition comprising an active principle capable of being subjected to high effect during its first passage through the intestine |
| 04/28/2004 | EP1411894A2 Pharmaceutical preparations containing ion exchange resins charged with active ingredients |
| 04/28/2004 | EP1411893A1 Flat, oral dosage form comprising particles containing active ingredients |
| 04/28/2004 | EP1411889A1 Cream for treatment of skin injured by the sun |
| 04/28/2004 | EP1411888A2 Sunscreen composition |
| 04/28/2004 | EP1411861A2 Biodegradable injectable implants and related methods of manufacture and use |
| 04/28/2004 | EP1411770A2 Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof |
| 04/28/2004 | EP1411765A1 Enhancement of the stability of oligonucleotides comprising phosphorothioate linkages by addition of water-soluble antioxidants |
| 04/28/2004 | EP1259190B1 Method for making, loading and sealing a cell or drug encapsulation device, and such a device |
| 04/28/2004 | EP1198489B1 Combinations for introducing nucleic acids into cells |
| 04/28/2004 | EP1150716B1 Pharmaceutical composition of hydrophobically modified hedgehog proteins and their use |
| 04/28/2004 | EP1140197B1 Soluble compositions of toremifene |
| 04/28/2004 | EP1128841B1 Pharmaceutical preparation containing a receptor-antagonist for treating blood-clotting disorders |
| 04/28/2004 | EP1126829B1 Particles coated with granulated crystalline ibuprofen |
| 04/28/2004 | EP1061946B1 Glp-1 derivatives with helix-content exceeding 25 %, forming partially structured micellar-like aggregates |
| 04/28/2004 | EP0883993B1 Antiviral materials |
| 04/28/2004 | EP0879048B1 Solid formulations containing trehalose |
| 04/28/2004 | EP0856054B1 Monoclonal antibody br110 and uses thereof |
| 04/28/2004 | EP0809515B1 Therapeutic inhibitor of vascular smooth muscle cells |
| 04/28/2004 | EP0787201B1 Poly(organo)phosphazenes for use in synthetic transfection systems |
| 04/28/2004 | EP0782455B1 Use of porphyrins in the treatment of multiple sclerosis |
| 04/28/2004 | CN1493052A Method for identification of T-cell epitopes and use for preparing molecules with reduced immunogenicity |
| 04/28/2004 | CN1492917A Function cubic liquid crystalline phase precursor and its preparation and using method |
| 04/28/2004 | CN1492876A Amphoteric sterols and the use thereof |
| 04/28/2004 | CN1492767A Modified anti-EGFR antibody with reduced immunogenicity |
| 04/28/2004 | CN1492763A Compositions for delivering bisphosphonates |
| 04/28/2004 | CN1492761A Injectable pharmaceutical composition for treatment and reversal of erectile dysfunction |
| 04/28/2004 | CN1492760A 环糊精制剂 Cyclodextrin formulation |
| 04/28/2004 | CN1492756A Amphoteric liposomes and the use thereof |
| 04/28/2004 | CN1492754A Cosmetic or pharmaceutical agent |
| 04/28/2004 | CN1491724A Polysaccharide system for gelling and thickening for treating glaucoma |
| 04/28/2004 | CN1491720A Inducer of blood vessel neogenesis |
| 04/28/2004 | CN1491642A Adhesive film agent and its preparing method |
| 04/28/2004 | CN1147472C Benzamide formulation with histone deacetylase inhibitor activity |
| 04/28/2004 | CN1147329C Device for trandermal electrotransport delivery of fentanyl and sufentanil |
| 04/28/2004 | CN1147322C Iron-dextran compound and its preparing process and use |
| 04/28/2004 | CN1147321C Process for preparing laevo threnoate compounds or complexes |
| 04/28/2004 | CN1147320C Suppositories |
| 04/28/2004 | CN1147319C Pharmaceutical hydrogel formulations, drug delivery devices and methods |
| 04/28/2004 | CN1147318C Recombined alpha-type interferon freeze-drying protective agent |
| 04/28/2004 | CN1147301C Progestin therapy with controlled bleeding |
| 04/28/2004 | CN1147295C Rapid release tablet comprising tolfenamic acid or a pharmaceutically acceptable salt thereof and its preparation |
| 04/28/2004 | CN1147293C Method for producing film-type dosage forms |
| 04/28/2004 | CN1147292C Double capsule for the administration of active principles in multiple therepies |
| 04/28/2004 | CN1147291C Enteric coating, comprising alginic acid, for an oral preparation |
| 04/28/2004 | CN1147290C Polyol composition |
| 04/28/2004 | CN1147289C Method and compositions for stabilizing acetylcholine compositions |
| 04/28/2004 | CN1147232C Antiparasitic formulations |
| 04/27/2004 | US6727355 Pharmaceutical composition for treatment of Duchenne muscular dystrophy |
| 04/27/2004 | US6727347 Method for preparing polycation based bioconjugates suitable for transporting different kinds of active substances within the body |
| 04/27/2004 | US6727287 Comprising less than 10% by weight of a toluene sulfonamide and a pharmaceutically acceptable carrier |
| 04/27/2004 | US6727283 Used to prepare an aqueous solution of sertraline; therapy and prophylaxis of depression, anorexia, chemical dependencies, anxiety-related disorders, premature ejaculation, cancer and post myocardial infarction |
| 04/27/2004 | US6727280 Especially administering to a subject suffering from a taxane-resistant colorectal carcinoma |
| 04/27/2004 | US6727243 Solid solution dissolved in a polymer |
| 04/27/2004 | US6726933 Rod-shaped mesoporous powder, humectant adsorbing powder, and cosmetic preparation using the same |
| 04/27/2004 | US6726932 Fatty acid-containing composition |
| 04/27/2004 | US6726927 Comprises core granulation formed by dry mixing drug or its salt with alkaline substance and pharmaceutical excipients which can be quantitatively filled into an empty hard gelatin capsule; provides gastrointestinal cytoprotective benefit |
| 04/27/2004 | US6726926 Disaccharide protector; frozen; preserved for longer than one year; shows excellent restoration ability in water |
| 04/27/2004 | US6726925 Bi-layer membrane comprising phospholipid and lysolipid; drug delivery, medical diagnosis |
| 04/27/2004 | US6726919 For inducing or maintaining anesthesia or sedation in a patient |
| 04/27/2004 | US6726918 Implanting bioerodible particle comprising steroidal antiinflammatory agent and polymer that delivers dexamethasone to vitreous; ophthalmology; uveitis, vision defects |
| 04/27/2004 | US6726915 Cosmetic or pharmaceutical composition in solid form comprising bis-acyl-amides |
| 04/27/2004 | US6726860 Production scale method of forming microparticles |
| 04/27/2004 | CA2296244C Adjuvants for use in vaccines |
| 04/27/2004 | CA2290974C Solubilized sertraline compositions |
| 04/27/2004 | CA2271750C Prolonged anesthesia in joints and body spaces |
| 04/27/2004 | CA2123651C Process of sugarless hard coating and products obtained therefrom |
| 04/22/2004 | WO2004033663A2 Carbohydrate-based synthetic vaccines for hiv |
| 04/22/2004 | WO2004033645A2 Methods of regulating body weight |
| 04/22/2004 | WO2004033620A2 Methods and compositions for therapeutic use of rna interference |
| 04/22/2004 | WO2004033484A2 Use of stable glutamine derivatives to improve drug absorption |
| 04/22/2004 | WO2004033424A1 Watersoluble prodrugs of propofol |